Swedish Orphan Biovitrum AB

2.15 £

Société biopharmaceutique suédoise développant et commercialisant des traitements pour maladies rares et graves.

Performance & Momentum

6 Months 31.46 %
1 Year 46.41 %
3 Years 84.98 %
5 Years 211.72 %

Similar stocks to Swedish Orphan Biovitrum AB

Anantys Community

Be the first to share your analysis on Swedish Orphan Biovitrum AB.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases